As of April 2024 Geron has a market cap of $2.09 Billion. This makes Geron the world's 3999th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.09 B | 82.95% |
2023 | $1.14 B | 24.2% |
2022 | $0.92 B | 134.89% |
2021 | $0.39 B | -20.43% |
2020 | $0.49 B | 81.66% |
2019 | $0.27 B | 45.79% |
2018 | $0.18 B | -34.97% |
2017 | $0.28 B | -13% |
2016 | $0.32 B | -57.13% |
2015 | $0.76 B | 50.2% |
2014 | $0.51 B | -17.4% |
2013 | $0.61 B | 237.29% |
2012 | $0.18 B | -5.62% |
2011 | $0.19 B | -69.41% |
2010 | $0.63 B | 23.87% |
2009 | $0.51 B | 38.89% |
2008 | $0.36 B | -14.42% |
2007 | $0.43 B | -30.15% |
2006 | $0.61 B | 10.81% |
2005 | $0.55 B | 34.12% |
2004 | $0.41 B | 6.18% |
2003 | $0.39 B | 339.64% |
2002 | $89.16 M | -58.14% |
2001 | $0.21 B |
On Apr 25th, 2024 the market cap of Geron was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | $81.38 B | 3,782.37% | ๐บ๐ธ USA |
Incyte INCY | $11.49 B | 448.14% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | $1.19 B | -42.82% | ๐บ๐ธ USA |
Bio-Techne TECH | $9.84 B | 369.84% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | $9.39 M | -99.55% | ๐บ๐ธ USA |